Clinical Trials Logo

Tinea Pedis clinical trials

View clinical trials related to Tinea Pedis.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05754463 Completed - Athlete Foot Clinical Trials

The Effect Of Plyometric Training On Balance And Proprioception In Different Branches Athletes

Plyometric
Start date: June 5, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of plyometric training on balance and proprioception in athletes in different branches. 54 athletes participated in the study. Two groups were included as 27 athletics and 27 karate groups. Plyometric training was applied to the athletes participating in our study, 2 days a week for 6 weeks, after 20 minutes of warming up and stretching movements before each training. Sociodemographic characteristics of the athletes were recorded. Dynamic balance Y balance test and static balance Stroke balance test; sense of proprioception was evaluated with Angle reproduction test.

NCT ID: NCT05363449 Completed - Tinea Pedis Clinical Trials

Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis

Start date: February 17, 2022
Phase: Phase 1
Study type: Interventional

This Phase 1 study has been designed to determine the safety, tolerability and pharmacokinetics (PK) of UHE 103 Cream compared to Naftin Cream, 2% under maximal use conditions for 2 weeks treatment in subjects with tinea cruris and/or tinea pedis

NCT ID: NCT04883593 Completed - Tinea Pedis Clinical Trials

A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.

Start date: September 3, 2020
Phase: Early Phase 1
Study type: Interventional

To evaluate and compare the safety and efficacy of TA103 in the treatment of tinea pedis.

NCT ID: NCT04789083 Completed - Nurse's Role Clinical Trials

The Effect of Propolis in Tinea Pedis Treatment: A Randomized Controlled Study

Start date: February 3, 2022
Phase: N/A
Study type: Interventional

Tineapedis is an important health problem. Providing foot care in tinea pedis treatment contributes positively to the treatment. In addition, alternative treatments can also be used. In this study, the randomization study group will be divided into three. Medical treatment and foot care training will be applied to the first group, medical treatment and propolis to the second group, medical treatment and plassebo to the control group. Foot care training will be given by nurse coaching. Times of all three groups and their response to treatment will be evaluated.

NCT ID: NCT04568577 Completed - Ankle Sprains Clinical Trials

Effects of the Elastic Taping on the Chronic Ankle Instability

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This study will analyze the effects of an elastic taping application protocol in individuals with chronic ankle instability. One group will perform a protocol with increased tape tension for five weeks while the other group will receive the same tape without tension during the same period.

NCT ID: NCT04439981 Completed - Athletes Foot Clinical Trials

Curcuma Extract Beneficial for Muscle Damage

Start date: April 8, 2019
Phase: N/A
Study type: Interventional

Muscle damage and inflammation is a clinical problem caused by the unimpeachable body adaptation of strenuous exercise through increasing free radicals. Antioxidants content in Curcuma is hypothesized to alleviate the free radicals. This study aimed to examine the effect of Curcuma extract in the form of ice cream to improve muscle damage and inflammation of soccer athletes caused by strenuous exercise. This study was experimental study with pre-post control group design. Male soccer athlete (n=20) were divided into treatment group (n=10) and control group (n=10). The treatment group was treated by Curcuma extract ice cream for 21 days. Blood samples of creatine kinase (as muscle damage marker) and IL-6 (as inflammation marker) were quantified.

NCT ID: NCT04265521 Completed - Skin Diseases Clinical Trials

Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet

Start date: March 3, 2020
Phase: N/A
Study type: Interventional

A prospective, open, post-market study that will enroll male and female subjects diagnosed with foot fungus and at least one of the following conditions: heel cracks, calluses and/or dry feet. The investigation will consist of approximately 48 subjects (considering a 10% drop-out/screening failure rate) fulfilling the eligibility criteria for the study. Each subject will be treated with the study product, BioCool Footcare (footbath), for 3 weeks. The study duration is estimated to 5 months including recruiting, treatment and follow-up period.

NCT ID: NCT04203342 Completed - Tinea Pedis Clinical Trials

A Therapeutic Equivalence Study of Ketoconazole Cream 2%

Start date: December 11, 2019
Phase: Phase 3
Study type: Interventional

Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis.

NCT ID: NCT04152226 Completed - Tinea Pedis Clinical Trials

Open Label, Single-dose, Dose Escalating Evaluation of the Safety and Tolerability of DBI-001 in Patients With T. Pedis

Start date: February 19, 2019
Phase: Phase 2
Study type: Interventional

This is an open- label, single- dose, dose escalating evaluation of the safety and tolerability of three dose levels of DBI-001 in patients with Tinea pedis. The purpose of the current protocol is to establish the safety and tolerability of a single application of J. lividum to the feet of patients with proven T. pedis. In addition, the effect of J liv on the T. pedis will also be evaluated.

NCT ID: NCT03897257 Completed - Tinea Pedis Clinical Trials

A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis

Start date: March 15, 2019
Phase: Phase 2
Study type: Interventional

The study is being done to determine and compare the safety and effectiveness of an investigational combination therapy (low and high concentrations) versus mono-therapy (low and high concentrations) or mono-therapy (fixed concentration) in subjects with moccasin type tinea pedis.